Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al.

New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment

(2017) Yameng Sun et al.   HEPATOLOGY

Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: implications for liver biopsy interpretation

(2016) Alberto Quaglia et al.   HISTOPATHOLOGY

Reversion of disease manifestations after HCV eradication

(2016) Adriaan J. van der Meer et al.   JOURNAL OF HEPATOLOGY

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

(2015) Eduardo Vilar-Gomez et al.   GASTROENTEROLOGY

Pathobiology of liver fibrosis: a translational success story

(2015) Youngmin A Lee et al.   GUT

Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’

(2015) Ulrich Beuers et al.   HEPATOLOGY

Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy

(2015) George V. Papatheodoridis et al.   JOURNAL OF HEPATOLOGY

Anticoagulant Therapy in Patients with Cirrhosis

(2015) Nicolas Intagliata et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Dismantling the myth of “autoanticoagulation” in cirrhosis: An old dogma dies hard

(2012) Stephen Caldwell et al.   HEPATOLOGY

A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis

(2012) Roberta D'Ambrosio et al.   HEPATOLOGY

The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis

(2012) Seung Up Kim et al.   JOURNAL OF HEPATOLOGY

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

(2012) Patrick Marcellin et al.   LANCET

Beyond “Cirrhosis”

(2011) Prodromos Hytiroglou et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension

(2011) Moon Young Kim et al.   JOURNAL OF HEPATOLOGY

Histological benefits of virological response to peginterferon alfa-2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis

(2010) G. T. EVERSON et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

(2010) Ting-Tsung Chang et al.   HEPATOLOGY

Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis

(2009) Guadalupe Garcia-Tsao et al.   HEPATOLOGY